Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer

1.7 million cases of breast cancer are diagnosed every year with 522,000 deaths. Molecular classifications of breast cancer have resulted in improved treatments. However, treatments for triple negative breast cancer (TNBC) are lacking. Analysis of molecular targets for TNBC is a priority. One potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Roseweir, Antonia K., McCall, Pamela, Scott, Alison, Liew, Benjamin, Lim, Zhi, Mallon, Elizabeth A., Edwards, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514900/
https://www.ncbi.nlm.nih.gov/pubmed/28415597
http://dx.doi.org/10.18632/oncotarget.16420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514900/
https://www.ncbi.nlm.nih.gov/pubmed/28415597
http://dx.doi.org/10.18632/oncotarget.16420

Ejemplares similares